Study ID: BDP-AR-101
Study Title
- Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol
Teva Identifier
- BDP-AR-101
ClinicalTrials.gov Identifier
- NCT01537692
Study Status
- Completed
Trial Condition(s)
- Female, Maleergic Rhinitis
Interventions
- Drug: BDP HFA Nasal Aerosol | Drug: BDP HFA Inhalation Aerosol (QVAR)
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 45 Years
Trial Duration
- 03/01/2009 - 06/01/2009
Phase
- Phase 1
Study Type
Interventional